News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
628,545 Results
Type
Article (48003)
Company Profile (94)
Press Release (580448)
Multimedia
Podcasts (56)
Webinars (12)
Section
Business (174753)
Career Advice (3000)
Deals (31016)
Drug Delivery (117)
Drug Development (76965)
Employer Resources (170)
FDA (15180)
Job Trends (14001)
News (305021)
Policy (30365)
Tag
Academia (2763)
Academic (1)
Accelerated approval (6)
Adcomms (26)
Allergies (89)
Alliances (42886)
ALS (95)
Alzheimer's disease (1446)
Antibody-drug conjugate (ADC) (136)
Approvals (15158)
Artificial intelligence (266)
Autoimmune disease (26)
Automation (16)
Bankruptcy (330)
Best Places to Work (11325)
BIOSECURE Act (16)
Biosimilars (99)
Biotechnology (70)
Bladder cancer (84)
Brain cancer (29)
Breast cancer (283)
Cancer (2277)
Cardiovascular disease (194)
Career advice (2532)
Career pathing (33)
CAR-T (161)
Cell therapy (437)
Cervical cancer (19)
Clinical research (62530)
Collaboration (801)
Company closure (1)
Compensation (324)
Complete response letters (25)
COVID-19 (2703)
CRISPR (42)
C-suite (258)
Cystic fibrosis (92)
Data (2209)
Decentralized trials (2)
Denatured (11)
Depression (53)
Diabetes (279)
Diagnostics (6380)
Digital health (19)
Diversity (5)
Diversity, equity & inclusion (39)
Drug discovery (121)
Drug pricing (116)
Drug shortages (31)
Duchenne muscular dystrophy (99)
Earnings (67832)
Editorial (45)
Employer branding (21)
Employer resources (148)
Events (96784)
Executive appointments (747)
FDA (16428)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (731)
Gene editing (109)
Generative AI (25)
Gene therapy (332)
GLP-1 (765)
Government (4750)
Grass and pollen (6)
Guidances (66)
Healthcare (18403)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (133)
Indications (28)
Infectious disease (2854)
Inflammatory bowel disease (141)
Inflation Reduction Act (10)
Influenza (54)
Intellectual property (97)
Interviews (605)
IPO (14277)
IRA (47)
Job creations (3063)
Job search strategy (2063)
Kidney cancer (11)
Labor market (31)
Layoffs (489)
Leadership (23)
Legal (6600)
Liver cancer (76)
Lung cancer (329)
Lymphoma (152)
Machine learning (7)
Management (61)
Manufacturing (302)
MASH (75)
Medical device (12655)
Medtech (12660)
Mergers & acquisitions (17262)
Metabolic disorders (723)
Multiple sclerosis (80)
NASH (23)
Neurodegenerative disease (106)
Neuropsychiatric disorders (32)
Neuroscience (2018)
NextGen: Class of 2025 (6430)
Non-profit (4566)
Now hiring (32)
Obesity (382)
Opinion (250)
Ovarian cancer (73)
Pain (91)
Pancreatic cancer (81)
Parkinson's disease (154)
Partnered (21)
Patents (236)
Patient recruitment (110)
Peanut (48)
People (54557)
Pharmaceutical (28)
Pharmacy benefit managers (14)
Phase I (19235)
Phase II (27468)
Phase III (21050)
Pipeline (1214)
Policy (153)
Postmarket research (2459)
Preclinical (8047)
Press Release (65)
Prostate cancer (105)
Psychedelics (37)
Radiopharmaceuticals (242)
Rare diseases (396)
Real estate (4895)
Recruiting (70)
Regulatory (21182)
Reports (36)
Research institute (2397)
Resumes & cover letters (471)
Rett syndrome (5)
RNA editing (5)
RSV (45)
Schizophrenia (79)
Series A (131)
Series B (81)
Service/supplier (6)
Sickle cell disease (57)
Special edition (15)
Spinal muscular atrophy (156)
Sponsored (34)
Startups (3094)
State (2)
Stomach cancer (15)
Supply chain (67)
Tariffs (40)
The Weekly (44)
Vaccines (724)
Venture capitalists (39)
Weight loss (262)
Women's health (27)
Worklife (20)
Date
Today (121)
Last 7 days (854)
Last 30 days (2538)
Last 365 days (31509)
2025 (10404)
2024 (33861)
2023 (38121)
2022 (49112)
2021 (53205)
2020 (52350)
2019 (45463)
2018 (34565)
2017 (30757)
2016 (29842)
2015 (34813)
2014 (26511)
2013 (21863)
2012 (23561)
2011 (24409)
2010 (21714)
Location
Africa (849)
Alabama (58)
Alaska (5)
Arizona (193)
Arkansas (12)
Asia (37484)
Australia (7396)
California (5660)
Canada (1941)
China (510)
Colorado (266)
Connecticut (251)
Delaware (143)
Europe (84343)
Florida (877)
Georgia (199)
Hawaii (1)
Idaho (54)
Illinois (523)
India (25)
Indiana (293)
Iowa (8)
Japan (157)
Kansas (96)
Kentucky (22)
Louisiana (12)
Maine (52)
Maryland (888)
Massachusetts (4069)
Michigan (229)
Minnesota (371)
Mississippi (2)
Missouri (83)
Montana (26)
Nebraska (24)
Nevada (62)
New Hampshire (67)
New Jersey (1667)
New Mexico (28)
New York (1644)
North Carolina (932)
North Dakota (9)
Northern California (2454)
Ohio (198)
Oklahoma (11)
Oregon (31)
Pennsylvania (1293)
Puerto Rico (13)
Rhode Island (29)
South America (1141)
South Carolina (21)
South Dakota (1)
Southern California (2154)
Tennessee (97)
Texas (858)
United States (21654)
Utah (179)
Virginia (148)
Washington D.C. (57)
Washington State (528)
West Virginia (3)
Wisconsin (52)
628,545 Results for "marken formerly known as marken time critical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Legal
Vanda Sues FDA Again, This Time Over Off-Label Use of Hetlioz for Jet Lag
Vanda is criticizing the FDA’s restrictions on information companies can provide regarding off-label use of approved medicines.
April 14, 2025
·
2 min read
·
Tristan Manalac
Pharm Country
Thubrikar Aortic Valve to Present Promising Initial Results of CE Mark-Enabling Study With Novel Optimum TAV™ at EuroPCR 2023
Thubrikar Aortic Valve, Inc., is happy to announce that results of the initial CE Mark-enabling study using the Optimum Transcatheter Aortic Valve (Optimum TAV™) in patients with severe aortic stenosis will be presented at the upcoming EuroPCR 2023 Conference.
May 2, 2023
·
3 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Pharm Country
Thubrikar Aortic Valve completes initial CE Mark-enabling TAVI-1 Study
Thubrikar Aortic Valve, Inc., announced today that it has completed the initial CE Mark-enabling study using the Optimum Transcatheter Aortic Valve (Optimum TAV™) in patients with severe aortic stenosis.
October 21, 2022
·
3 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Government
COVID-19 Critic Marty Makary Is Trump’s Likely Pick for FDA Top Post
Makary is a pancreatic surgeon at Johns Hopkins who became known for battling medical mistakes and in recent years has been an outspoken critic of COVID-19 policies.
November 21, 2024
·
2 min read
·
Tristan Manalac
IN PARTNERSHIP WITH ECLIPSEBIO
Beyond Black Box: How Data-Driven AI Is Transforming RNA Medicine Development
AI offers tremendous potential but there are critical and time-consuming flaws in black box AI predictions.
March 31, 2025
·
7 min read
·
BioSpace Insights
Press Releases
Celltrion’s Remdantry™, previously known as Inflectra®, will be available in Canada as of April 1, 2025
March 27, 2025
·
3 min read
Press Releases
Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment
May 1, 2025
·
5 min read
Press Releases
Tenon Medical, Inc. Announces Timing of First Quarter 2025 Financial Results
April 29, 2025
·
2 min read
1 of 62,855
Next
